Trials / Sponsors / EirGenix, Inc.
EirGenix, Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Efficacy and Safety Study of EG1206A (EirGenix' Pertuzumab) Compared With EU-sourced Perjeta® (Pertuzumab) in Early Breast Cancer | Phase 3 | 2025-05-01 |
| Completed | A Pharmacokinetic Study Comparing EG1206A and Perjeta (Pertzumab) in Healthy Male Volunteers Breast Cancer | Phase 1 | 2022-05-16 |
| Completed | Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cance Breast Cancer | Phase 3 | 2018-10-16 |
| Completed | A Pharmacokinetic Study Comparing EG12014 and Herceptin (Trastuzumab) in Healthy Male Volunteers Healthy | Phase 1 | 2016-03-22 |